AI Pharma Pioneer Kevin Weil's Warp Journey
The saga follows former OpenAI product chief Kevin Weil as he leaves the AI giant to found Warp Sciences, a startup that applies artificial intelligence to drug discovery. After raising $215 million, the company has now opened a U.S.-based contract research organization to accelerate AI‑driven pharmaceutical research, marking its move from funding to operational execution.
-
Warp Sciences launches U.S.-based CRO for AI-driven drug research
The startup combines robotics and AI to accelerate drug discovery by automating lab experiments and generating real-world data for training AI models. Founded by Kevin Weil, Solomon Reisberg,…
1 source -
Former OpenAI product chief Kevin Weil launches AI science startup Warp Sciences with $215 million
Former OpenAI Chief Product Officer Kevin Weil has launched Warp Sciences, an AI-for-science startup that has emerged from stealth with $215 million in funding. The company, led by Weil as CEO,…
3 sources